Departamento académico
(FM) Medicina Interna
Publicacións (182) Publicacións nas que participase algún/ha investigador/a
2022
-
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19
The Lancet Oncology, Vol. 23, Núm. 7, pp. e334-e347
-
A Simple Prognostic Scoring System for Hepatocellular Carcinoma Treated with Selective Internal Radiation Therapy
Digestive Diseases, Vol. 40, Núm. 3, pp. 322-334
-
A minimal bile salt excretory pump promoter allows bile acid-driven physiological regulation of transgene expression from a gene therapy vector
Cell and Bioscience, Vol. 12, Núm. 1
-
A new animal model of atrophy–hypertrophy complex and liver damage following Yttrium-90 lobar selective internal radiation therapy in rabbits
Scientific Reports, Vol. 12, Núm. 1
-
A nutrigenetic tool for precision dietary management of non-alcoholic fatty liver disease deeming insulin resistance markers
Panminerva medica, Vol. 64, Núm. 4, pp. 485-496
-
Activation of the unfolded protein response (Upr) is associated with cholangiocellular injury, fibrosis and carcinogenesis in an experimental model of fibropolycystic liver disease
Cancers, Vol. 14, Núm. 1
-
Acute Eosinophilic Pneumonia Following mRNA COVID-19 Vaccination: A Case Report
Archivos de Bronconeumologia, Vol. 58, pp. 53-54
-
Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 49, Núm. 13, pp. 4716-4726
-
Alpha-Fetoprotein as a Potential Surrogate Biomarker for Atezolizumab + Bevacizumab Treatment of Hepatocellular Carcinoma
Clinical Cancer Research, Vol. 28, Núm. 16, pp. 3537-3545
-
Analysis of the albumin-bilirubin score as an indicator of improved liver function among hepatitis C virus patients with sustained viral response after direct-acting antiviral therapy
JGH Open, Vol. 6, Núm. 7, pp. 496-502
-
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
The Lancet, Vol. 399, Núm. 10320, pp. 143-151
-
BACH2 restricts NK cell maturation and function, limiting immunity to cancer metastasis
Journal of Experimental Medicine, Vol. 219, Núm. 12
-
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
Journal of Hepatology, Vol. 76, Núm. 3, pp. 681-693
-
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
The Lancet, Vol. 400, Núm. 10349, pp. 359-368
-
Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial
Journal of Cancer Research and Clinical Oncology, Vol. 148, Núm. 2, pp. 475-485
-
Bile Processing Protocol for Improved Proteomic Analysis
Methods in Molecular Biology (Humana Press Inc.), pp. 1-10
-
Broad virus inactivation using inorganic micro/nano-particulate materials
Materials Today Bio, Vol. 13
-
C5a elevation in convalescents from severe COVID-19 is not associated with early complement activation markers C3bBbP or C4d
Frontiers in Immunology, Vol. 13
-
CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome
Science Advances, Vol. 8, Núm. 39
-
CAR-T Cells for the Treatment of Lung Cancer
Life, Vol. 12, Núm. 4